BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34810201)

  • 21. NOTCH pathway inactivation promotes bladder cancer progression.
    Maraver A; Fernandez-Marcos PJ; Cash TP; Mendez-Pertuz M; Dueñas M; Maietta P; Martinelli P; Muñoz-Martin M; Martínez-Fernández M; Cañamero M; Roncador G; Martinez-Torrecuadrada JL; Grivas D; de la Pompa JL; Valencia A; Paramio JM; Real FX; Serrano M
    J Clin Invest; 2015 Feb; 125(2):824-30. PubMed ID: 25574842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathobiology of Notch2 in lung cancer.
    Motooka Y; Fujino K; Sato Y; Kudoh S; Suzuki M; Ito T
    Pathology; 2017 Aug; 49(5):486-493. PubMed ID: 28666642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate.
    Ireland AS; Micinski AM; Kastner DW; Guo B; Wait SJ; Spainhower KB; Conley CC; Chen OS; Guthrie MR; Soltero D; Qiao Y; Huang X; Tarapcsák S; Devarakonda S; Chalishazar MD; Gertz J; Moser JC; Marth G; Puri S; Witt BL; Spike BT; Oliver TG
    Cancer Cell; 2020 Jul; 38(1):60-78.e12. PubMed ID: 32473656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The FACT inhibitor CBL0137 Synergizes with Cisplatin in Small-Cell Lung Cancer by Increasing
    De S; Lindner DJ; Coleman CJ; Wildey G; Dowlati A; Stark GR
    Cancer Res; 2018 May; 78(9):2396-2406. PubMed ID: 29440145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular pathology of small cell lung cancer: Overview from studies on neuroendocrine differentiation regulated by ASCL1 and Notch signaling.
    Ito T
    Pathol Int; 2024 May; 74(5):239-251. PubMed ID: 38607250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.
    Byers LA; Wang J; Nilsson MB; Fujimoto J; Saintigny P; Yordy J; Giri U; Peyton M; Fan YH; Diao L; Masrorpour F; Shen L; Liu W; Duchemann B; Tumula P; Bhardwaj V; Welsh J; Weber S; Glisson BS; Kalhor N; Wistuba II; Girard L; Lippman SM; Mills GB; Coombes KR; Weinstein JN; Minna JD; Heymach JV
    Cancer Discov; 2012 Sep; 2(9):798-811. PubMed ID: 22961666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
    Qian Y; Du Z; Xing Y; Zhou T; Chen T; Shi M
    Mol Med Rep; 2017 Nov; 16(5):6034-6040. PubMed ID: 28849037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Notch1 controls cell invasion and metastasis in small cell lung carcinoma cell lines.
    Hassan WA; Yoshida R; Kudoh S; Hasegawa K; Niimori-Kita K; Ito T
    Lung Cancer; 2014 Dec; 86(3):304-10. PubMed ID: 25456735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DLL3 regulates the migration and invasion of small cell lung cancer by modulating Snail.
    Furuta M; Kikuchi H; Shoji T; Takashima Y; Kikuchi E; Kikuchi J; Kinoshita I; Dosaka-Akita H; Sakakibara-Konishi J
    Cancer Sci; 2019 May; 110(5):1599-1608. PubMed ID: 30874360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion.
    Chalishazar MD; Wait SJ; Huang F; Ireland AS; Mukhopadhyay A; Lee Y; Schuman SS; Guthrie MR; Berrett KC; Vahrenkamp JM; Hu Z; Kudla M; Modzelewska K; Wang G; Ingolia NT; Gertz J; Lum DH; Cosulich SC; Bomalaski JS; DeBerardinis RJ; Oliver TG
    Clin Cancer Res; 2019 Aug; 25(16):5107-5121. PubMed ID: 31164374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures.
    Tlemsani C; Pongor L; Elloumi F; Girard L; Huffman KE; Roper N; Varma S; Luna A; Rajapakse VN; Sebastian R; Kohn KW; Krushkal J; Aladjem MI; Teicher BA; Meltzer PS; Reinhold WC; Minna JD; Thomas A; Pommier Y
    Cell Rep; 2020 Oct; 33(3):108296. PubMed ID: 33086069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer.
    Szczepny A; Rogers S; Jayasekara WSN; Park K; McCloy RA; Cochrane CR; Ganju V; Cooper WA; Sage J; Peacock CD; Cain JE; Burgess A; Watkins DN
    Oncogene; 2017 Sep; 36(39):5544-5550. PubMed ID: 28581526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Regulation and mechanism of Notch signaling pathway in small cell lung cancer].
    Zhang XM; Wang JX; Lei XG; Cheng H; Wang LL; Yao GY
    Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):95-9. PubMed ID: 20388374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Notch1 Deficiency Induces Tumor Cell Accumulation Inside the Bronchiolar Lumen and Increases TAZ Expression in an Autochthonous
    Meder L; Florin A; Ozretić L; Nill M; Koker M; Meemboor S; Radtke F; Diehl L; Ullrich RT; Odenthal M; Büttner R; Heukamp LC
    Pathol Oncol Res; 2021; 27():596522. PubMed ID: 34257546
    [No Abstract]   [Full Text] [Related]  

  • 35. Dll4-Fc, an inhibitor of Dll4-notch signaling, suppresses liver metastasis of small cell lung cancer cells through the downregulation of the NF-κB activity.
    Kuramoto T; Goto H; Mitsuhashi A; Tabata S; Ogawa H; Uehara H; Saijo A; Kakiuchi S; Maekawa Y; Yasutomo K; Hanibuchi M; Akiyama S; Sone S; Nishioka Y
    Mol Cancer Ther; 2012 Dec; 11(12):2578-87. PubMed ID: 22989420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FGFR1 Is Critical for RBL2 Loss-Driven Tumor Development and Requires PLCG1 Activation for Continued Growth of Small Cell Lung Cancer.
    Kim KB; Kim Y; Rivard CJ; Kim DW; Park KS
    Cancer Res; 2020 Nov; 80(22):5051-5062. PubMed ID: 32973083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma.
    Schaffer BE; Park KS; Yiu G; Conklin JF; Lin C; Burkhart DL; Karnezis AN; Sweet-Cordero EA; Sage J
    Cancer Res; 2010 May; 70(10):3877-83. PubMed ID: 20406986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two distinct Notch signals, Delta-like 4/Notch1 and Jagged-1/Notch2, antagonistically regulate chemical hepatocarcinogenesis in mice.
    Nakano Y; Nakao S; Sueoka M; Kasahara D; Tanno Y; Sumiyoshi H; Itoh T; Miyajima A; Hozumi K; Inagaki Y
    Commun Biol; 2022 Jan; 5(1):85. PubMed ID: 35064244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of Notch-mediated transcription by a bovine herpesvirus 1 encoded protein (ORF2) that is expressed in latently infected sensory neurons.
    Liu Y; Jones C
    J Neurovirol; 2016 Aug; 22(4):518-28. PubMed ID: 26846632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of small-cell lung cancer associates with STING pathway activation and is enhanced by ATR and TOP1 inhibition.
    Li X; Li Y; Zhao Z; Miao N; Liu G; Deng L; Wei S; Hou J
    Cancer Med; 2023 Feb; 12(4):4864-4881. PubMed ID: 35957613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.